Atomoxetine (ATX)

Clinical Update

Atomoxetine for Children and Adolescents: An Update

Topics: ADHD | Atomoxetine (ATX) | Attention Deficit Hyperactivity Disorder

Atomoxetine (ATX, Strattera) was approved by the FDA for ADHD treatment in 2002, and since then has become a second- or third-line option (after stimulants and sometimes after central alpha-agonists) for ADHD in both children and adults. With the recent approval of another non-stimulant ADHD medication (viloxazine, brand name Qelbree), it’s a good tim

Read More